These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 305406)

  • 21. Cellular sensitization in chronic myeloid leukaemia patients to leukaemic blast antigens.
    Gangal SG; Damle NK; Khare AG; Advani SH
    Br J Cancer; 1979 Sep; 40(3):391-6. PubMed ID: 292450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunological diagnosis of leukemias in childhood (author's transl)].
    Schwenk HU; Schneider U
    Monatsschr Kinderheilkd (1902); 1978 Mar; 126(3):105-12. PubMed ID: 347255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ALL masquerading as AUL.
    Greaves MF; Bell R; Amess J; Lister TA
    Leuk Res; 1983; 7(6):735-46. PubMed ID: 6582340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunophenotype of clonogenic cells in myeloid leukaemia.
    Kabral A; Bradstock KF; Grimsley P; Favaloro EJ
    Leuk Res; 1988; 12(1):51-9. PubMed ID: 3162752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ia+T10+ blast cells in acute lymphoblastic leukaemia are precursors of T+ and B+ cells.
    Miljković AK; Isaković K; Matejić T; Stojanović B
    Adv Exp Med Biol; 1985; 186():1017-25. PubMed ID: 3931426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Pan-myeloid" reagent: the monoclonal antibody MCS-2 in the routine immunodiagnostic service of leukemia phenotyping.
    Drexler HG; Sagawa K; Menon M; Minowada J
    Jpn J Cancer Res; 1985 Mar; 76(3):235-9. PubMed ID: 3922842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immunological classification of leukaemia based on a rapid microcytotoxicity test.
    Billing RJ; Foon KA; Linker-Israeli M
    Clin Exp Immunol; 1982 Jul; 49(1):142-8. PubMed ID: 6957278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Separation of lymphoid and myeloid blasts in the mixed blast crisis of chronic myelogenous leukemia: no evidence for Ig gene rearrangement in CALLA-positive blasts.
    Ha K; Freedman MH; Hrincu A; Petsche D; Poon A; Gelfand EW
    Blood; 1985 Dec; 66(6):1404-8. PubMed ID: 2415187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'Pseudo-lymphoid' leukaemia with unusual features: ultrastructural, immunological, cytogenetic and molecular studies.
    Matutes E; Foroni L; Amin S; de Oliveira MP; Brito-Babapulle V; Luzzatto L; Catovsky D
    Eur J Haematol; 1987 Apr; 38(4):303-9. PubMed ID: 3038599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphoid antigens on blast cells in the agranular metamorphosis of chronic myelogenous leukaemia.
    Bacigalupo A; Santini G; Piaggio G; Risso M; van Lint MT; Carella M; Damasio EE; Raffo MC; Marmont AM
    Acta Haematol; 1978; 60(5):280-90. PubMed ID: 101014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphoid crisis with T-cell phenotypes in a patient with Philadelphia chromosome negative chronic myeloid leukaemia.
    Soda H; Kuriyama K; Tomonaga M; Yao E; Amenomori T; Yoshida Y; Matsuo T; Jinnai I; Sadamori N; Ichimaru M
    Br J Haematol; 1985 Apr; 59(4):671-9. PubMed ID: 3872678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic myelocytic leukemia terminating in blast cell crisis with lymphoblastic characteristics.
    Walters TR; Minowada J; Tsubota T; Kataoka K; Han T
    Pediatrics; 1978 Nov; 62(5):795-800. PubMed ID: 281667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneous blast cell crises in Philadelphia negative chronic granulocytic leukaemia.
    Hughes A; McVerry BA; Walker H; Bradstock KF; Hoffbrand AV; Janossy G
    Br J Haematol; 1981 Apr; 47(4):563-9. PubMed ID: 6938237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
    Shumak KH; Baker MA; Taub RN; Coleman MS
    Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological distinction of adult T cell leukaemia from T cell acute lymphoblastic leukaemia.
    Tsubota T; Miyoshi I; Uno J; Hiraki S; Kobayashi T; Sato U; Kimura I
    Clin Exp Immunol; 1980 Jul; 41(1):130-5. PubMed ID: 6969147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B cell markers in Ph1-positive acute lymphoblastic leukemia.
    Alimena G; De Rossi G; Gastaldi R; Guglielmi C; Mandelli F
    Nouv Rev Fr Hematol (1978); 1980; 22(3):275-80. PubMed ID: 6970921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specificity of heteroantisera to human acute leukemia-associated antigens.
    Baker MA; Ramachandar K; Taub RN
    J Clin Invest; 1974 Dec; 54(6):1273-8. PubMed ID: 4140196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serological detection of B-cell ("Ia-like") antigens in serum of normal donor and in some sera of leukaemic patients.
    Koubek K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):408-15. PubMed ID: 6182060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of human T and B lymphocyte cell-surface markers on leukaemic cells.
    Brown G; Greaves MF; Lister TA; Rapson N; Papamichael M
    Lancet; 1974 Sep; 2(7883):753-5. PubMed ID: 4143016
    [No Abstract]   [Full Text] [Related]  

  • 40. [Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis].
    Baryshnikov AIu
    Eksp Onkol; 1984; 6(5):53-5. PubMed ID: 6239771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.